AngioDynamics | ANGO - Ebit


AngioDynamics reported $-4.05M in EBIT for its fiscal quarter ending in February of 2025.





Ebit Change Date
AngioDynamics USD -4.05M 1.54M Feb/2025
AtriCure USD 208K 4.03M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
ICU Medical USD 26.86M 52K Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 7.54M Sep/2025
Mesa Laboratories USD 4.45M 2.5M Sep/2024
Orthofix International USD -18.9M 6.01M Sep/2024
Smiths GBP 242M 21M Dec/2025
Surmodics USD -322K 2.13M Dec/2023
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD 112.65M 44.3M Sep/2025
Terumo JPY 45.1B 10.79B Sep/2025
Trinity Biotech USD -10.02M 8.31M Dec/2024